ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sun Pharmaceuticals Industries's annualizedNet Income for the quarter that ended in Dec. 2023 was ₹100,950 Mil.
Sun Pharmaceuticals Industries's average Total Assets over the quarter that ended in Dec. 2023 was ₹794,412 Mil. Therefore, Sun Pharmaceuticals Industries's annualized ROA % for the quarter that ended in Dec. 2023 was 12.71%.
The historical rank and industry rank for Sun Pharmaceuticals Industries's ROA % or its related term are showing as below:
NSE:SUNPHARMA'
s ROA % Range Over the Past 10 Years
Min: 3.33 Med: 7.13 Max: 12.58
Current: 11.39
During the past 13 years, Sun Pharmaceuticals Industries's highest ROA % was 12.58%. The lowest was 3.33%. And the median was 7.13%.
NSE:SUNPHARMA's ROA % is ranked better than 87.52% of 1082
companies
in the Drug Manufacturers industry
Industry Median: 1.535
vs NSE:SUNPHARMA: 11.39
Sun Pharmaceuticals Industries ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sun Pharmaceuticals Industries's ROA %
For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sun Pharmaceuticals Industries's ROA % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's ROA % distribution charts can be found below:
* The bar in red indicates where Sun Pharmaceuticals Industries's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2023) net income data.
ROA % is displayed in the 30-year financial page.
Sun Pharmaceuticals Industries (NSE:SUNPHARMA) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Sun Pharmaceuticals Industries ROA % Related Terms
Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.
Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.
Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSE:SUNPHARMA has been successfully added to your 